Adenoma Detection Rates Linked to Colorectal Cancer and Mortality

A study of nearly 315,000 colonoscopies performed by 136 gastroenterologists found that adenoma detection rates closely tracked the future risk of colorectal cancer. The study was published April 3 in the New England Journal of Medicine.

bioTheranostics Signs Agreement with National PPO Network Prime Health Services

bioTheranostics, Inc., the leading genomic solutions provider for cancer diagnosis, recently signed a contract with Prime Health Services, Inc., a national preferred provider organization network, to cover the company’s genomic tests for breast cancer patients and patients with metastatic disease.

CAP Awarded More Than $1.25 Million in CDC Grants

The College of American Pathologists (CAP), the world’s largest organization of board-certified pathologists, has been awarded two grants from the Centers for Disease Control and Prevention (CDC). The funding, totaling more than $1.25 million, will be used to improve the adoption of evidence-based laboratory testing guidelines and to standardize reporting of biomarker test results to cancer registries. The grant dollars will be used over a five-year period.

Strand Genomics Announces Availability Of Technology Solutions To Power Expansion Of Personalized Medicine Centers In U.S.

Strand Genomics, Inc. (Strand) recently announced its recent unveiling of a full suite of technology solutions that will support its expansion of Strand Centers for Genomics & Personalized Medicine (Strand Centers) into the U.S. At last month’s ACMG 2014 Annual Clinical Genetics Meeting in Nashville, Strand demonstrated how its StrandOmics and Avadis-NGS Server Edition software support the end-to-end clinical genomics services that will be offered by Strand Centers as the company seeks to expand its successful model from India into the United States.

Updated CME Program Is Designed To Help Clinicians Reduce Heart Failure Patient Hospital Readmissions

Critical Diagnostics recently announced that an updated accredited, self-learning program entitled, “Reducing Heart Failure Readmissions: Case Studies Utilizing Biomarkers for Risk Stratification,” is available now online at www.heartfailurecases.com.